NM_000208.4:c.652+28661T>C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000208.4(INSR):c.652+28661T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.511 in 147,330 control chromosomes in the GnomAD database, including 20,625 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.51   (  20625   hom.,  cov: 24) 
Consequence
 INSR
NM_000208.4 intron
NM_000208.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -2.20  
Publications
9 publications found 
Genes affected
 INSR  (HGNC:6091):  (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015] 
INSR Gene-Disease associations (from GenCC):
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.05). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.694  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4 | c.652+28661T>C | intron_variant | Intron 2 of 21 | ENST00000302850.10 | NP_000199.2 | ||
| INSR | NM_001079817.3 | c.652+28661T>C | intron_variant | Intron 2 of 20 | NP_001073285.1 | |||
| INSR | XM_011527988.3 | c.652+28661T>C | intron_variant | Intron 2 of 21 | XP_011526290.2 | |||
| INSR | XM_011527989.4 | c.652+28661T>C | intron_variant | Intron 2 of 20 | XP_011526291.2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| INSR | ENST00000302850.10 | c.652+28661T>C | intron_variant | Intron 2 of 21 | 1 | NM_000208.4 | ENSP00000303830.4 | |||
| INSR | ENST00000341500.9 | c.652+28661T>C | intron_variant | Intron 2 of 20 | 1 | ENSP00000342838.4 | ||||
| INSR | ENST00000598216.1 | n.627+28661T>C | intron_variant | Intron 2 of 9 | 1 | 
Frequencies
GnomAD3 genomes  0.511  AC: 75184AN: 147254Hom.:  20594  Cov.: 24 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
75184
AN: 
147254
Hom.: 
Cov.: 
24
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.511  AC: 75243AN: 147330Hom.:  20625  Cov.: 24 AF XY:  0.506  AC XY: 36123AN XY: 71354 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
75243
AN: 
147330
Hom.: 
Cov.: 
24
 AF XY: 
AC XY: 
36123
AN XY: 
71354
show subpopulations 
African (AFR) 
 AF: 
AC: 
27815
AN: 
39664
American (AMR) 
 AF: 
AC: 
5758
AN: 
14558
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1687
AN: 
3456
East Asian (EAS) 
 AF: 
AC: 
1490
AN: 
5082
South Asian (SAS) 
 AF: 
AC: 
2234
AN: 
4724
European-Finnish (FIN) 
 AF: 
AC: 
3601
AN: 
9130
Middle Eastern (MID) 
 AF: 
AC: 
129
AN: 
286
European-Non Finnish (NFE) 
 AF: 
AC: 
30817
AN: 
67492
Other (OTH) 
 AF: 
AC: 
1030
AN: 
2040
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.497 
Heterozygous variant carriers
 0 
 1624 
 3249 
 4873 
 6498 
 8122 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 664 
 1328 
 1992 
 2656 
 3320 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1527
AN: 
3476
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.